Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for thrombophilia.

Dorit Blickstein1

  • 1Hemato-gynecology Service, Institute of Hematology, Beilinson Hospital, Rabin Medical Center, Petach-Tikva 49100, Israel. doritb2@clalit.org.il

Obstetrics and Gynecology Clinics of North America
|September 12, 2006
PubMed
Summary

Thrombophilia screening can benefit high-risk patients for venous thromboembolism (VTE) and aid family planning. However, widespread testing is not advised until cost-effective tools are available.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acquired hemophilia A following influenza vaccination: a case report and literature review.

Annals of hematology·2026
Same author

Persistent Challenges in Direct Oral Anticoagulant Prescriptions: Time to Optimize Medication Safety in Hospital and Community Settings.

The Israel Medical Association journal : IMAJ·2025
Same author

Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID-19 infection.

Vox sanguinis·2023
Same author

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Reply to comment from Doyle et al.

Journal of thrombosis and haemostasis : JTH·2022
Same author

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.

Journal of thrombosis and haemostasis : JTH·2021
Same author

Should patients treated with oral anti-coagulants be operated on within 48 h of hip fracture?

Journal of thrombosis and thrombolysis·2020

Area of Science:

  • Medical Diagnostics
  • Hematology
  • Genetics

Background:

  • Venous thromboembolism (VTE) poses significant health risks.
  • Identifying individuals with thrombophilia can inform clinical management.
  • Current screening tools may lack cost-effectiveness for broad application.

Purpose of the Study:

  • To evaluate the utility of thrombophilia screening in high-risk VTE patients.
  • To explore the benefits of family screening for VTE risk.
  • To provide guidance on appropriate laboratory testing strategies.

Main Methods:

  • Clinical evaluation of high-risk patients.
  • Assessment of VTE risk factors.
  • Review of current thrombophilia screening protocols.

Main Results:

  • Thrombophilia screening may improve clinical outcomes in select high-risk VTE patients.
  • Family screening can facilitate primary prophylaxis and reproductive counseling.
  • Expert physician evaluation is crucial for tailoring diagnostic and treatment plans.

Conclusions:

  • Thrombophilia screening is beneficial for specific high-risk VTE cases.
  • Cost-effective screening methods are needed for wider implementation.
  • Personalized medical assessment should guide laboratory testing and VTE management.

Related Experiment Videos